| |
Intervention
|
control
| | | | |
|---|
|
Clinical topic
|
n
|
Mean before (SD)
|
Mean after (SD)
|
n
|
Mean before (SD)
|
Mean after (SD)
|
Ba (95% CI)
|
icc
|
Direction
|
p
|
|---|
|
Anaemia
|
35
|
176.8 (172.2)
|
209.4 (174.6)
|
53
|
199.6 (146.3)
|
232.5 (177.7)
|
−9.1 (−96.1, 77.9)
|
0.60
|
↓
|
0.829
|
|
Rheumatic complaints
|
39
|
13.3 (22.9)
|
11.6 (20.7)
|
49
|
12.9 (16.2)
|
14.9 (27.5)
|
3.2 (−8.1, 14.6)
|
0.55
|
↓
|
0.551b
|
|
Prostate complaints
|
26
|
34.7 (24.6)
|
30.4 (29.3)
|
62
|
39.1 (27.4)
|
41.8 (29.5)
|
6.9 (−0.7, 14.6)
|
0.07
|
↓
|
0.072
|
|
Chlamydia infections
|
30
|
11.4 (21.5)
|
14.7 (23.3)
|
58
|
7.4 (8.8)
|
5.8 (9.5)
|
−5.7 (−12.0, 0.5)
|
0.40
|
↑
|
0.069b
|
|
Thyroid dysfunction
|
29
|
204.8 (159.9)
|
191.3 (135.4)
|
59
|
163.3 (153.2)
|
191.7 (152.8)
|
36.6 (10.5, 62.7)
|
0.00
|
↓
|
0.007
|
|
Perimenopausal complaints
|
24
|
5.7 (5.5)
|
3.8 (3.5)
|
64
|
6.1 (6.7)
|
7.3 (8.0)
|
3.2 (0.1, 6.4)
|
0.10
|
↓
|
0.046b
|
- The desired direction of change is given in the column headed ‘direction’. Numbers represent the number of tests prescribed per 6 months per 1000 patients
-
n = number of practices
-
aAdjusted difference between groups at end of intervention, corrected for baseline
-
bStatistically significant interaction
- Rheumatic complaints
- P10: B (95% CI):−3.0 (−13.9, 8.0). p: 0.560
- P90: B (95% CI): 14.8 (2.1, 27.4). p: 0.025
- Chlamydia infections
- P10: B (95% CI):−2.3 (−9.0, 4.4) p: 0.482
- P90: B (95% CI):−10.4 (−17.6,−3.3) p: 0.006
- Perimenopausal complaints
- P10: B (95% CI): 0.7 (−3.0, 4.5). p: 0.696
- P90: B (95% CI): 6.6 (2.4, 10.7). p: 0.002
